Compare Stocks: SHC, MEDP, CRL, and ICLR

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CRL Charles River Laboratories International	$290.17 +3.9%	$228.65	$144.26 ▼ $294.56	$13.85B	1.38	926,377 shs	987,408 shs
ICLR Icon	$172.49 +3.3%	$163.15	$66.57 ▼ $203.91	$13.21B	1.21	1.36 million shs	687,875 shs
MEDP Medpace	$608.27 +3.0%	$544.34	$373.00 ▼ $677.90	$16.98B	1.15	349,254 shs	169,049 shs
SHC Sotera Health	$19.00 +2.6%	$17.64	$13.09 ▼ $19.85	$5.42B	1.77	2.90 million shs	2.68 million shs

7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CRL Charles River Laboratories International	-2.39%	-0.75%	+24.71%	+78.97%	+77.79%
ICLR Icon	-1.42%	+0.89%	-1.74%	+45.15%	-6.45%
MEDP Medpace	-1.14%	-2.51%	+9.78%	+39.92%	+27.52%
SHC Sotera Health	-1.54%	-3.14%	+4.28%	+19.04%	+17.15%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CRL Charles River Laboratories International	$290.17 +3.9%	$228.65	$144.26 ▼ $294.56	$13.85B	1.38	926,377 shs	987,408 shs
ICLR Icon	$172.49 +3.3%	$163.15	$66.57 ▼ $203.91	$13.21B	1.21	1.36 million shs	687,875 shs
MEDP Medpace	$608.27 +3.0%	$544.34	$373.00 ▼ $677.90	$16.98B	1.15	349,254 shs	169,049 shs
SHC Sotera Health	$19.00 +2.6%	$17.64	$13.09 ▼ $19.85	$5.42B	1.77	2.90 million shs	2.68 million shs

7 Best Space Stocks to Own in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CRL Charles River Laboratories International	-2.39%	-0.75%	+24.71%	+78.97%	+77.79%
ICLR Icon	-1.42%	+0.89%	-1.74%	+45.15%	-6.45%
MEDP Medpace	-1.14%	-2.51%	+9.78%	+39.92%	+27.52%
SHC Sotera Health	-1.54%	-3.14%	+4.28%	+19.04%	+17.15%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CRL Charles River Laboratories International	2.69	Moderate Buy	$255.65	-11.90% Downside
ICLR Icon	2.41	Hold	$170.40	-1.21% Downside
MEDP Medpace	2.23	Hold	$584.18	-3.96% Downside
SHC Sotera Health	2.73	Moderate Buy	$21.50	13.16% Upside

Current Analyst Ratings Breakdown

Latest SHC, MEDP, CRL, and ICLR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/12/2026	MEDP Medpace	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C+) ➝ Buy (B-)
8/11/2026	SHC Sotera Health	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C) ➝ Hold (C+)
8/10/2026	CRL Charles River Laboratories International	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$235.00 ➝ $300.00
8/10/2026	CRL Charles River Laboratories International	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$300.00
8/10/2026	CRL Charles River Laboratories International	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$264.00
8/7/2026	CRL Charles River Laboratories International	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$260.00 ➝ $300.00
8/7/2026	SHC Sotera Health	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$23.00 ➝ $25.00
8/7/2026	SHC Sotera Health	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$19.00 ➝ $22.00
8/7/2026	SHC Sotera Health	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$22.00 ➝ $25.00
8/7/2026	SHC Sotera Health	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$16.00 ➝ $18.00
8/6/2026	CRL Charles River Laboratories International	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$291.00

(Data available from 8/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CRL Charles River Laboratories International	$4.02B	3.45	$22.74 per share	12.76	$64.39 per share	4.51
ICLR Icon	$8.25B	1.60	$17.82 per share	9.68	$120.07 per share	1.44
MEDP Medpace	$2.53B	6.71	$17.89 per share	34.00	$16.30 per share	37.32
SHC Sotera Health	$1.16B	4.66	$1.29 per share	14.78	$2.13 per share	8.92

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CRL Charles River Laboratories International	-$144.34M	-$4.85	N/A	23.12	2.90	-5.96%	15.75%	6.51%	11/4/2026 (Estimated)
ICLR Icon	$229.34M	$4.26	40.49	15.94	6.76	3.99%	8.02%	4.56%	10/28/2026 (Estimated)
MEDP Medpace	$451.12M	$17.06	35.65	31.73	2.58	17.67%	110.15%	24.84%	10/28/2026 (Estimated)
SHC Sotera Health	$77.94M	$0.57	33.33	19.59	N/A	13.44%	40.12%	7.55%	11/3/2026 (Estimated)

Latest SHC, MEDP, CRL, and ICLR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q2 2026	SHC Sotera Health	$0.2389	$0.26	+$0.0211	$0.19	$309.70 million	$321.38 million
8/5/2026	Q2 2026	CRL Charles River Laboratories International	$2.77	$3.02	+$0.25	-$0.03	$980.53 million	$1.00 billion
7/30/2026	Q1 2026	ICLR Icon	$2.55	$2.56	+$0.01	$0.94	$2.00 billion	$2.06 billion
7/22/2026	Q2 2026	MEDP Medpace	$3.98	$4.25	+$0.27	$4.25	$689.51 million	$707.33 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CRL Charles River Laboratories International	N/A	N/A	N/A	N/A	N/A
ICLR Icon	N/A	N/A	N/A	N/A	N/A
MEDP Medpace	N/A	N/A	N/A	N/A	N/A
SHC Sotera Health	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CRL Charles River Laboratories International	0.92	1.35	1.04
ICLR Icon	0.23	0.95	0.95
MEDP Medpace	N/A	0.73	0.73
SHC Sotera Health	3.33	2.80	2.55

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CRL Charles River Laboratories International	98.91%
ICLR Icon	95.61%
MEDP Medpace	77.98%
SHC Sotera Health	91.03%

Insider Ownership

Company	Insider Ownership
CRL Charles River Laboratories International	1.30%
ICLR Icon	44.00%
MEDP Medpace	20.50%
SHC Sotera Health	15.36%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CRL Charles River Laboratories International	19,700	47.74 million	47.12 million	Optionable
ICLR Icon	40,100	76.57 million	42.88 million	Optionable
MEDP Medpace	6,200	27.91 million	22.19 million	Optionable
SHC Sotera Health	3,000	285.38 million	241.54 million	Optionable

SHC, MEDP, CRL, and ICLR Headlines

Recent News About These Companies

Insider Selling: Sotera Health (NASDAQ:SHC) Chairman Sells 850,000 Shares

2 hours ago | marketbeat.com

Research Tools & Consumables Stocks Q2 Recap: Benchmarking Sotera Health Company (NASDAQ:SHC)

August 19 at 12:20 PM | finance.yahoo.com

State of Wyoming Buys Shares of 56,651 Sotera Health Company $SHC

August 16 at 7:03 AM | marketbeat.com

Sotera Health Company (SHC): Buy, sell, or hold post Q2 earnings?

August 14, 2026 | msn.com

Sotera Health Company’s Q2 earnings call: Our top 5 analyst questions

August 13, 2026 | msn.com

Sotera Health (SHC) Q2 2026 Earnings Call Transcript

August 13, 2026 | finance.yahoo.com

Michael Rutz Sells 150,000 Shares of Sotera Health (NASDAQ:SHC) Stock

August 13, 2026 | americanbankingnews.com

Insider Selling: Sotera Health (NASDAQ:SHC) Insider Sells $2,826,000.00 in Stock

August 12, 2026 | insidertrades.com

Sotera Health (NASDAQ:SHC) Insider Sells $2,826,000.00 in Stock

August 11, 2026 | marketbeat.com

Sotera Health Company (NASDAQ:SHC) Given Average Recommendation of "Moderate Buy" by Analysts

August 11, 2026 | americanbankingnews.com

Sotera Health Company (SHC) Reported Positive Results Amid Litigation Wins

August 10, 2026 | insidermonkey.com

Quantinno Capital Management LP Has $2.83 Million Position in Sotera Health Company $SHC

August 10, 2026 | marketbeat.com

Sotera Health's (SHC) Overweight Rating Reiterated at Piper Sandler

August 10, 2026 | americanbankingnews.com

Sotera Health (NASDAQ:SHC) Price Target Raised to $18.00

August 10, 2026 | americanbankingnews.com

Renaissance Technologies LLC Reduces Holdings in Sotera Health Company $SHC

August 9, 2026 | marketbeat.com

Bullfrog AI (NASDAQ:BFRGW) versus Sotera Health (NASDAQ:SHC) Head to Head Comparison

August 9, 2026 | americanbankingnews.com

SHC Q2 deep dive: Broad-based growth, leadership transition, and strategic investments shape outlook

August 8, 2026 | msn.com

Sotera Health (NASDAQ:SHC) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS

August 7, 2026 | marketbeat.com

Piper Sandler Reaffirms "Overweight" Rating for Sotera Health (NASDAQ:SHC)

August 7, 2026 | marketbeat.com

JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Sotera Health (NASDAQ:SHC) Stock

August 7, 2026 | marketbeat.com

Sotera Health Q2 Earnings Call Highlights

August 7, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

SHC, MEDP, CRL, and ICLR Company Descriptions

Charles River Laboratories International NYSE:CRL

$290.17 +10.98 (+3.93%)

Closing price 03:59 PM Eastern

Extended Trading

$290.65 +0.49 (+0.17%)

As of 07:45 PM Eastern

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It also provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Icon NASDAQ:ICLR

$172.49 +5.44 (+3.26%)

Closing price 04:00 PM Eastern

Extended Trading

$172.40 -0.09 (-0.05%)

As of 07:30 PM Eastern

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, it offers adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.

Medpace NASDAQ:MEDP

$608.27 +17.97 (+3.04%)

Closing price 04:00 PM Eastern

Extended Trading

$608.81 +0.54 (+0.09%)

As of 07:30 PM Eastern

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

Sotera Health NASDAQ:SHC

$19.00 +0.49 (+2.65%)

Closing price 04:00 PM Eastern

Extended Trading

$18.98 -0.02 (-0.13%)

As of 07:30 PM Eastern

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems. The company also provides microbiological and analytical chemistry testing, as well as technical assistance, regulatory consulting, and advisory services. It serves medical devices, pharmaceuticals, food safety, agricultural products, cancer treatment, and high-performance materials industries, as well as commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SHC, MEDP, CRL, and ICLR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SHC, MEDP, CRL, and ICLR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SHC, MEDP, CRL, and ICLR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

SHC, MEDP, CRL, and ICLR Company Descriptions

Charles River Laboratories International NYSE:CRL

Icon NASDAQ:ICLR

Medpace NASDAQ:MEDP

Sotera Health NASDAQ:SHC

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SHC, MEDP, CRL, and ICLR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SHC, MEDP, CRL, and ICLR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SHC, MEDP, CRL, and ICLR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

SHC, MEDP, CRL, and ICLR Company Descriptions

Charles River Laboratories International NYSE:CRL

Icon NASDAQ:ICLR

Medpace NASDAQ:MEDP

Sotera Health NASDAQ:SHC

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools